Original Research Article
Year: 2023 | Month: May | Volume: 13 | Issue: 5 | Pages: 250-267
DOI: https://doi.org/10.52403/ijhsr.20230530
Description of Lung Cancer Occurrence Characteristics at Siloam MRCCC Semanggi Hospital in 2020 Due to the Covid-19 Pandemic
Efhata Surya Diapari Pohan1, Joyna Getruida Sopaheluwakan1, Vidi Posdo A. Simarmata2
1Department of Surgery, Faculty of Medicine, Universitas Kristen Indonesia, Jakarta
2Department of Medical Community, Faculty of Medicine, Universitas Kristen Indonesia, Jakarta
Corresponding Author: Efhata Surya Diapari Pohan
ABSTRACT
Lung cancer is one of the most common types of cancer worldwide and the number one cause of death in Indonesia. As the name implies, lung cancer is a disease activity in which cells in the body develop out of control and are localized in the lungs. Lung cancer has many underlying etiologies and risk factors, but the majority is due to smoking habits which are still high. Now, the world is being hit by the COVID-19 pandemic, which makes lung cancer patients have to be vigilant because they have a high risk of severity if infected. This study aims to describe the characteristics of the incidence of lung cancer at Siloam MRCCC Semanggi Hospital in 2020 during the COVID-19 pandemic. This research is a type of descriptive analytic research. The use of data comes from secondary data from archives of anatomical pathology laboratories, with the inclusion criteria for the sample being all patients diagnosed with lung cancer in the 2019-2020 period and having complete archives and data on the results of anatomical pathology examinations. Based on the results of the analysis, it was found that 35.5% of cases were distributed in the age group of 60-69 years, 58.6% were male, 70.4% were of the Adenocarcinoma type, 45.5% were advised to carry out further examination of the target of therapy, 15.9% used tissue biopsy as a histopathological examination technique and 32.5% used pleural effusion specimens for cytological examination.
Key words: Lung cancer, characteristics, therapeutic targets, COVID-19